Influenza News and Research

Latest Influenza News and Research

Two cases of MIS-C after laboratory-confirmed SARS-CoV-2 breakthrough infections in fully vaccinated adolescent patients

Researchers investigated whether COVID-19 vaccination effectively protected adolescents in the United States from multisystem inflammatory syndrome (MIS).

2 Jun 2022

New discovery could lead to highly effective ways to treat influenza

It happens every year, especially in winter. A virus saunters into your wide-open respiratory tract, worms its way into lung cells, and, next thing you know, you're lying in bed with a fever, aches, and chills - classic symptoms of influenza, or flu.

1 Jun 2022

SARS-CoV-2 variant emergence patterns across Alaska

A new study preprint server assesses the pattern of SARS-CoV-2 variant emergence across Alaska.

1 Jun 2022

Inverse relationship identified between SARS-CoV-2 and influenza infections

A new study identifies the potential correlations that exist between SARS-CoV-2 and influenza infections.

1 Jun 2022

Tracking the emergence of potential drug-resistant mutations in SARS-CoV-2 proteins

Researchers hypothesized that the emergence of resistant SARS-CoV-2 variants can be anticipated by identifying possible escape mutations already present in the existing SARS-CoV-2 populations.

1 Jun 2022

Robust and highly multiplexed assay for identification of SARS-CoV-2 variants

Researchers compared the performance of a highly multiplexed mass spectrometry-based commercial assay to identify SARS-CoV-2 variants.

31 May 2022

The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

Researchers evaluated the impact of CMV seropositivity on humoral and cellular immune responses generated after double and/or triple mRNA vaccination against SARS-CoV-2 among the elderly.

31 May 2022

HIV research enables knowledge transfer for improved COVID-19 response

Global virology and immunology networks that were originally developed for HIV vaccine research were rapidly adapted to study COVID-19.

31 May 2022

Study investigates whether people with breakthrough SARS-CoV-2 infection develop post-acute sequelae

Researchers characterized long COVID-19 after a breakthrough COVID-19 infection.

30 May 2022

Study shows how stress has a major impact on the immune system's ability to fight infections

Acute stress can be detrimental to fighting off infection, especially COVID-19, and increases the chance of dying in mouse models.

30 May 2022

Excess deaths in Canada during COVID-19 pandemic vary widely by province, analysis shows

An analysis of excess deaths in Canada during the COVID-19 pandemic shows wide variation by province and underscores the need for better and consistent data for current and future health crisis management.

30 May 2022

Zoonotic and public health implications of bovine and human brucellosis in Ethiopia

Announcing a new article publication for Zoonoses journal. Bovine brucellosis is endemic and widely distributed in Ethiopia.

27 May 2022

SARS-CoV-2 genome analysis could boost disease surveillance

Continued monitoring of the evolution of the virus that causes COVID-19 as the pandemic progresses could strengthen disease surveillance systems and aid preparedness for new variants, a study suggests.

27 May 2022

COVID-19 found to be among the top 10 causes of mortality in children and youth in the United States

Researchers retrieved CDC data for causes of death by age group for 2019 and compared it to the cumulative and annualized COVID-19 mortality between March 2020 and April 2022.

27 May 2022

Overestimation of population immunity resulted in lack of preparedness and U.S. Delta variant surge

When the delta variant of SARS-CoV-2 hit the United States in summer 2021, it led to a larger-than-expected surge in cases, hospitalizations and deaths.

26 May 2022

Inappropriate antibiotic prescriptions for children associated with excess health-care costs

Antibiotics inappropriately prescribed to nonhospitalized children resulted in at least $74 million in excess health-care costs in the U.S. in 2017, according to a new study from Washington University School of Medicine in St. Louis and The Pew Charitable Trusts.

26 May 2022

Novavax missed its global moonshot but is angling to win over mRNA defectors

Novavax hitched its wagon to the global coronavirus pandemic. Before most Americans truly grasped the scope of the danger, the small Maryland biotech startup had secured $1.6 billion in U.S. funding for its covid vaccine. Its moonshot goal: delivering 2 billion shots to the world by mid-2021.

26 May 2022

Study describes the symptom profiles of the main variants of SARS-CoV-2

Researchers assessed the severe SARS-CoV-2 variant-specific COVID-19 symptoms among residents of England.

26 May 2022

Model predicts scenarios that reveal the benefit of updating COVID vaccines

In a recent study posted to the bioRxiv* preprint server, scientists analyzed the necessity of revamping the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines to tackle the current dominant circulating viral variants.

26 May 2022

Vaccinated people with breakthrough SARS-CoV-2 infection can experience debilitating long COVID

Even vaccinated people with mild breakthrough COVID-19 infections can experience debilitating, lingering symptoms that affect the heart, brain, lungs and other parts of the body, according to new research from Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System.

25 May 2022

Influenza News and Research

Latest Influenza News and Research

Two cases of MIS-C after laboratory-confirmed SARS-CoV-2 breakthrough infections in fully vaccinated adolescent patients

New discovery could lead to highly effective ways to treat influenza

SARS-CoV-2 variant emergence patterns across Alaska

Inverse relationship identified between SARS-CoV-2 and influenza infections

Tracking the emergence of potential drug-resistant mutations in SARS-CoV-2 proteins

Robust and highly multiplexed assay for identification of SARS-CoV-2 variants

The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

HIV research enables knowledge transfer for improved COVID-19 response

Study investigates whether people with breakthrough SARS-CoV-2 infection develop post-acute sequelae

Study shows how stress has a major impact on the immune system's ability to fight infections

Excess deaths in Canada during COVID-19 pandemic vary widely by province, analysis shows

Zoonotic and public health implications of bovine and human brucellosis in Ethiopia

SARS-CoV-2 genome analysis could boost disease surveillance

COVID-19 found to be among the top 10 causes of mortality in children and youth in the United States

Overestimation of population immunity resulted in lack of preparedness and U.S. Delta variant surge

Inappropriate antibiotic prescriptions for children associated with excess health-care costs

Novavax missed its global moonshot but is angling to win over mRNA defectors

Study describes the symptom profiles of the main variants of SARS-CoV-2

Model predicts scenarios that reveal the benefit of updating COVID vaccines

Vaccinated people with breakthrough SARS-CoV-2 infection can experience debilitating long COVID

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Influenza News and Research

Latest Influenza News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in